Temozolomide 100 MG capsule 14S
Ended Awarded
- Contract number
- SPE2DR26FQN1T
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,358
Award facts
- Contract value 100% obligated
- $3,358.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, the pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Temozolomide 100 mg capsules (quantity 14) with a ceiling value of $3,358.08. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by October 21, 2025. The award represents a continuation of AmerisourceBergen's extensive role in federal pharmaceutical procurement, leveraging the company's significant Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as the primary vehicle for global pharmaceutical support to military and federal healthcare systems.
Temozolomide is a chemotherapy agent commonly used in the treatment of certain cancers, including glioblastoma and other malignancies. This delivery order fulfills federal medical supply requirements through AmerisourceBergen's established pharmaceutical distribution capabilities, which span multiple therapeutic domains including oncology, neurology, endocrinology, and infectious disease management. The company's role as a prime pharmaceutical vendor for the Defense Health Agency and U.S. Coast Guard underscores its importance to the federal healthcare supply chain, particularly for military medical programs requiring reliable access to specialty pharmaceutical products.
Quick answers
Who was awarded contract SPE2DR26FQN1T?
SPE2DR26FQN1T was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 20, 2025.
How much is contract SPE2DR26FQN1T worth?
The government has obligated $3,358 on SPE2DR26FQN1T.
Is contract SPE2DR26FQN1T an order under another contract?
Yes. SPE2DR26FQN1T is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQN1T competed?
The extent of competition for SPE2DR26FQN1T was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award